Skip to main content
. 2021 Mar 23;110(8):1299–1307. doi: 10.1007/s00392-021-01837-8

Fig. 3.

Fig. 3

Fixed-effects meta-analysis model of all trials, excluding AFFIRM-AHF, detailing the pooled effect of intravenous iron on the composite of first hospitalisations for heart failure or cardiovascular mortality (a), and first hospitalisation for heart failure (b) and cardiovascular mortality (c) alone. Although not included in the pooled analysis, odds ratios and 95% confidence intervals are presented for AFFIRM-AHF for comparison. IV intravenous, CI confidence interval